Biomea Fusion (BMEA) Earnings Date & Reports

Biomea Fusion Inc is a a clinical stage diabetes and obesity medicines company focused on the discovery and development of oral, small molecule drugs to treat and improve the lives of patients with diabetes, obesity, and other metabolic diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BMEA is expected to report earnings to rise 95.42% to -23 cents per share on November 03

Biomea Fusion BMEA Stock Earnings Reports

Q3'26

Est.

$-0.23

Q2'26

Beat

by $0.09

Q1'26

Beat

by $0.06

Q4'25

Beat

by $0.29

Q3'25

Beat

by $0.02

The last earnings report on August 05 showed earnings per share of -11 cents, beating the estimate of -20 cents. With 447.15K shares outstanding, the current market capitalization sits at 93.50M.

View a ticker or compare two or three

BMEA

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for BMEA